Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02087995 · ClinicalTrials.gov registry record · NA

Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm

A NA study of Diabetes Mellitus, sponsored by DexCom.

Completed
Registry status
NA
Development phase
51
Enrollment target
3
Study locations

NCT02087995 is a NA study of Diabetes Mellitus that has completed, run by DexCom. The registered enrollment target is 51 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02087995, a NA study of Diabetes Mellitus, has completed, sponsored by DexCom.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target
3
Study locations

Study Summary

To establish the performance of the Dexcom G4 Platinum with a Modified Algorithm continuous monitoring system when compared to a laboratory reference measurement.

Conditions Studied

Interventions

  • DEVICE Continuous Glucose Monitoring

Study Locations (3)

California

  • John Muir Physician Network Clinical Research - Concord
  • AMCR Institute - Escondido
  • Diablo Clinical Research, Inc. - Walnut Creek

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2013-12
Est. Completion 2014-03
Phase NA

Sponsor

DexCom

26 total trials

What the Registry Record Tells You About NCT02087995

The ClinicalTrials.gov registry entry for NCT02087995 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitoring is the first listed.

NCT02087995 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02087995 about?

NCT02087995 is a clinical study titled "Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm". To establish the performance of the Dexcom G4 Platinum with a Modified Algorithm continuous monitoring system when compared to a laboratory reference measurement.

What is the current status of trial NCT02087995?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2013-12. Estimated completion is 2014-03.

What conditions does trial NCT02087995 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT02087995?

The interventions under investigation include: Continuous Glucose Monitoring (DEVICE).

Who is sponsoring clinical trial NCT02087995?

This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02087995 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.